Skip to main content

Table 5 Odds Ratio and 95% CI from Multivariable analysis for 90 days bundle payment

From: Economics of the Management of Craniospinal Chordoma and Chondrosarcoma and the feasibility of the bundled payment model

  

All patients (N = 2041)

  

Group 1

Group 2

Group 3

  

Skull and face

Vertebral column

Sacrum/ coccyx

Cofactor

Category

n = 1214 (69.1%)

n = 297 (16.9%)

n = 246 (14%)

Age

+  10 year

0.9 (0.888, 0.97)

0.8 (0.827, 0.974)

0.8 (0.809, 0.966)

Gender

Female vs Male

0.9 (0.847, 1.051)

1.1 (0.928, 1.444)

0.9 (0.761, 1.281)

Insurance

Medicaid vs Commercial

0.5 (0.428, 0.692)

0.3 (0.174, 0.64)

0.4 (0.267, 0.838)

type

Medicare vs Commercial

0.7 (0.646, 0.93)

0.8 (0.534, 1.297)

0.5 (0.27, 1.2)

Elixhauser

Score 2 vs 1

1.1 (1.008, 1.363)

1.4 (1.084, 1.992)

1.3 (0.957, 1.79)

score

Score 3 vs 1

1.4 (1.273, 1.696)

1.5 (1.149, 2.078)

1.4 (1.063, 1.92)